- Home
- MAIA vs ITRG Comparison
MAIA vs ITRG Comparison
Compare MAIA & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAIA | ITRG |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9M | 482.5M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | MAIA | ITRG |
|---|---|---|
| Price | $1.16 | $4.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 911.7K | ★ 1.7M |
| Earning Date | 11-07-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $219,125,000.00 |
| Revenue This Year | N/A | $1,016.77 |
| Revenue Next Year | N/A | $7.81 |
| P/E Ratio | ★ N/A | $50.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $0.79 |
| 52 Week High | $2.74 | $4.40 |
Technical Indicators
Market Signals| Indicator | MAIA | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 65.88 |
| Support Level | $1.07 | $3.53 |
| Resistance Level | $1.75 | $4.40 |
| Average True Range (ATR) | 0.17 | 0.22 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 12.50 | 71.35 |
Price Performance
Historical ComparisonAbout MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.